SMTL ID : 8aq5.1

KRAS G12C IN COMPLEX WITH GDP AND COMPOUND 16

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 2 residues within 4Å: Chain A: S.18 Ligands: GDP.3 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:S.18, H2O.1, H2O.1, H2O.3, H2O.4

1 x NZ6: 1-[6-[4-(5-chloranyl-6-methyl-1~{H}-indazol-4-yl)-5-methyl-3-phenyl-pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]propan-1-one(Covalent)

NZ6.2: 21 residues within 4Å: Chain A: G.11, C.13, K.17, P.35, T.59, A.60, G.61, Q.62, E.64, Y.65, S.66, R.69, D.70, M.73, H.96, Y.97, Q.100, I.101, R.103, V.104 Ligands: GDP.3 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:P.35, A:R.69, A:M.73, A:Q.100, A:Q.100, A:I.101, A:V.104, A:V.104 Hydrogen bonds: A:K.17, A:S.66, A:D.70, A:D.70, A:R.103 Water bridges: A:R.69 pi-Stacking: A:H.96, A:Y.97

1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)

GDP.3: 21 residues within 4Å: Chain A: A.12, C.13, G.14, V.15, G.16, K.17, S.18, A.19, F.29, V.30, D.31, Y.33, N.117, K.118, D.120, L.121, S.146, A.147, K.148 Ligands: MG.1, NZ6.2 19 PLIP interactions: 19 interactions with chain A Hydrogen bonds: A:G.14, A:V.15, A:G.16, A:K.17, A:S.18, A:A.19, A:V.30, A:N.117, A:K.118, A:K.118, A:S.146, A:A.147, A:K.148 Water bridges: A:S.18, A:S.18 Salt bridges: A:K.17, A:D.120 pi-Stacking: A:F.29, A:F.29

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lorthiois, E. et al., JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRAS G12C for the Treatment of Solid Tumors. J.Med.Chem. (2022)

Release Date

2022-12-07

Peptides

GTPase KRas: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

GTPase KRas

Related Entries With Identical Sequence